Piramal buys Mallinckrodt’s pain drug portfolio
Piramal’s critical care business is a global player in the hospital generics segment
Author
Head and neck cancer market offers fertile ground for investors as disease understanding improves
According to GBI Research, there are 112 first-in-class programmes in the head and neck cancer pipeline, acting on 87 distinct…
The data integrity triad
Chinmoy Roy, Data Integrity SME, US and Arjun Guha Thakurta, Director, Life Science Consulting, a ConvalGroup Company, India,…
Russia’s pharma market to double to $39 bn by 2021
Implementation of a state programme to improve the healthcare industry has also had a positive impact on domestic production
French pharma market to stagnate as govt embraces generics to cut health expenditure
The market is set to decline from $35.5 bn in 2017 to $34.16 bn in 2021
Indian pharma industry continues to face headwinds: ICRA
Increased regulatory scrutiny and consolidation of supply chain in the US market resulting in pricing pressures along with…
Taro Pharmaceuticals in agreement with Thallion Pharmaceuticals
To acquire all of the issued and outstanding shares of Thallion Pharmaceuticals
The Social Way to Success
India Pharma Inc needs to leverage the potential of social media to up its game in times to come
DIA to organise pharmacovigilance conference
The conference will be held in Mumbai on March 24 and 25, 2017
Indian pharma cos need to join forces to counter IP threats
A key takeaway from the 6th Annual Pharma IPR Indian 2017 was the need for concerted action among Indian pharma peers on domestic…